These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
188 related items for PubMed ID: 3074652
21. Specific association of HLA-DR4 with increased prevalence and level of insulin autoantibodies in first-degree relatives of patients with type I diabetes. Ziegler R, Alper CA, Awdeh ZL, Castano L, Brink SJ, Soeldner JS, Jackson RA, Eisenbarth GS. Diabetes; 1991 Jun; 40(6):709-14. PubMed ID: 2040387 [Abstract] [Full Text] [Related]
22. Prognostically significant heterogeneity of cytoplasmic islet cell antibodies in relatives of patients with type I diabetes. Gianani R, Pugliese A, Bonner-Weir S, Shiffrin AJ, Soeldner JS, Erlich H, Awdeh Z, Alper CA, Jackson RA, Eisenbarth GS. Diabetes; 1992 Mar; 41(3):347-53. PubMed ID: 1551494 [Abstract] [Full Text] [Related]
23. Occult CD45 T cell developmental defect in type 1 diabetes. Faustman DL. Diabete Metab; 1993 Mar; 19(5):446-57. PubMed ID: 8056125 [Abstract] [Full Text] [Related]
24. Islet cell and insulin autoantibodies in organ-specific autoimmune patients. Their behaviour and predictive value for the development of type 1 (insulin-dependent) diabetes mellitus. A 10-year follow-up study. Betterle C, Presotto F, Pedini B, Moro L, Slack RS, Zanette F, Zanchetta R. Diabetologia; 1987 May; 30(5):292-7. PubMed ID: 3301480 [Abstract] [Full Text] [Related]
25. Autoantibodies to a 38-kDa glycosylated islet cell membrane-associated antigen in (pre)type 1 diabetes: association with IA-2 and islet cell autoantibodies. Winnock F, Christie MR, Batstra MR, Aanstoot HJ, Weets I, Decochez K, Jopart P, Nicolaij D, Gorus FK, Belgian Diabetes Registry. Diabetes Care; 2001 Jul; 24(7):1181-6. PubMed ID: 11423499 [Abstract] [Full Text] [Related]
27. [Early diagnosis of type-1 diabetes. Limits, possibilities and outlook]. Kuglin B, Bertrams J, Kolb H, Gries FA. Dtsch Med Wochenschr; 1989 May 12; 114(19):762-7. PubMed ID: 2653770 [No Abstract] [Full Text] [Related]
28. Pre-type 1 (insulin-dependent) diabetes: common endocrinological course despite immunological and immunogenetic heterogeneity. Srikanta S, Ganda OP, Jackson RA, Brink SJ, Fleischnick E, Yunis E, Alper C, Soeldner JS, Eisenbarth GS. Diabetologia; 1984 Jul 12; 27 Suppl():146-8. PubMed ID: 6383919 [Abstract] [Full Text] [Related]
29. Predictive value of islet cell and insulin autoantibodies for type 1 (insulin-dependent) diabetes mellitus in a population-based study of newly-diagnosed diabetic and matched control children. Landin-Olsson M, Palmer JP, Lernmark A, Blom L, Sundkvist G, Nyström L, Dahlquist G. Diabetologia; 1992 Nov 12; 35(11):1068-73. PubMed ID: 1473617 [Abstract] [Full Text] [Related]
33. Autoantibodies to pancreatic islet cells and insulin in IDDM families: the GAW5 data. Maclaren NK, Riley WJ, McCulloch DK, Palmer JP. Genet Epidemiol; 1989 Nov 12; 6(1):39-41. PubMed ID: 2659429 [Abstract] [Full Text] [Related]
34. Value of insulin autoantibodies as serum markers for insulin-dependent diabetes mellitus. Wilkin T, Hoskins PJ, Armitage M, Rodier M, Casey C, Diaz JL, Pyke DA, Leslie RD. Lancet; 1985 Mar 02; 1(8427):480-1. PubMed ID: 2857852 [Abstract] [Full Text] [Related]
39. Antibodies to the M(r) 64,000 (64K) protein in islet cell antibody positive non-diabetic individuals indicate high risk for impaired beta-cell function. Seissler J, Hering B, Richter W, Glück M, Yassin N, Bretzel RG, Boehm BO, Federlin K, Scherbaum WA. Diabetologia; 1992 Jun 09; 35(6):550-4. PubMed ID: 1612228 [Abstract] [Full Text] [Related]
40. Early development and spreading of autoantibodies to epitopes of IA-2 and their association with progression to type 1 diabetes. Naserke HE, Ziegler AG, Lampasona V, Bonifacio E. J Immunol; 1998 Dec 15; 161(12):6963-9. PubMed ID: 9862731 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]